U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.15-0.14 (-2.23%)
At close: 4:00PM EDT
People also watch
NVAXGALECLDXONCSSRPT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue35,368.36140,572.11110,456.766
Cost of Revenue---
Gross Profit35,368.36140,572.11110,456.766
Operating Expenses
Research Development88,712.03557,791.92334,095.039
Selling General and Administrative23,892.26318,063.8915,857.688
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-76,235.937-34,283.702-39,495.961
Income from Continuing Operations
Total Other Income/Expenses Net2,384.8111,482.632679.604
Earnings Before Interest and Taxes-73,740.339-31,200.603-36,140.133
Interest Expense---
Income Before Tax-73,740.339-31,200.603-36,140.133
Income Tax Expense--2,097.766-
Minority Interest96.269245.828310.618
Net Income From Continuing Ops-72,629.552-26,587.139-33,445.489
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-73,740.339-29,187.606-36,121.713
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-73,740.339-29,187.606-36,121.713